POH: Anti-fat Peptide Patch progresses
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Later from Avecho Biotechnology
- Appointment of Joint CEO - Dr Esra Ogru
- December 2009 Appendix 4E and Statutory Financial Report
- June 2010 Half Yearly Appendix 4D and Financial Report
- Phosphagenics Launches Australian Skincare Products
- POH Global Agreement with Novartis Animal Health
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology